nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—breast cancer	0.181	1	CbGaD
Levetiracetam—ABCC2—Tamoxifen—breast cancer	0.052	0.107	CbGbCtD
Levetiracetam—ABCB1—Toremifene—breast cancer	0.0464	0.0954	CbGbCtD
Levetiracetam—ABCC2—Paclitaxel—breast cancer	0.0405	0.0832	CbGbCtD
Levetiracetam—ABCC2—Irinotecan—breast cancer	0.0399	0.0821	CbGbCtD
Levetiracetam—ABCC2—Carboplatin—breast cancer	0.0381	0.0783	CbGbCtD
Levetiracetam—ABCC2—Vinblastine—breast cancer	0.0355	0.073	CbGbCtD
Levetiracetam—ABCB1—Lapatinib—breast cancer	0.0339	0.0696	CbGbCtD
Levetiracetam—ABCC2—Docetaxel—breast cancer	0.0293	0.0601	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—breast cancer	0.0218	0.0448	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—breast cancer	0.0211	0.0434	CbGbCtD
Levetiracetam—ABCB1—Vinorelbine—breast cancer	0.0188	0.0386	CbGbCtD
Levetiracetam—ABCB1—Tamoxifen—breast cancer	0.017	0.0348	CbGbCtD
Levetiracetam—ABCB1—Mitoxantrone—breast cancer	0.0165	0.034	CbGbCtD
Levetiracetam—ABCB1—Gemcitabine—breast cancer	0.0146	0.03	CbGbCtD
Levetiracetam—ABCB1—Paclitaxel—breast cancer	0.0132	0.0271	CbGbCtD
Levetiracetam—ABCB1—Irinotecan—breast cancer	0.013	0.0267	CbGbCtD
Levetiracetam—ABCB1—Vinblastine—breast cancer	0.0116	0.0238	CbGbCtD
Levetiracetam—ABCB1—Docetaxel—breast cancer	0.00954	0.0196	CbGbCtD
Levetiracetam—SV2A—nipple—breast cancer	0.00734	0.206	CbGeAlD
Levetiracetam—ABCB1—Doxorubicin—breast cancer	0.00711	0.0146	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—breast cancer	0.00689	0.0142	CbGbCtD
Levetiracetam—SV2A—endometrium—breast cancer	0.00443	0.124	CbGeAlD
Levetiracetam—SV2A—pituitary gland—breast cancer	0.00401	0.112	CbGeAlD
Levetiracetam—SV2A—adrenal gland—breast cancer	0.00358	0.1	CbGeAlD
Levetiracetam—SV2A—female gonad—breast cancer	0.00334	0.0936	CbGeAlD
Levetiracetam—CACNA1B—pituitary gland—breast cancer	0.00277	0.0777	CbGeAlD
Levetiracetam—SV2A—lymph node—breast cancer	0.00215	0.0602	CbGeAlD
Levetiracetam—CACNA1B—lymph node—breast cancer	0.00148	0.0416	CbGeAlD
Levetiracetam—ABCC2—female reproductive system—breast cancer	0.000822	0.023	CbGeAlD
Levetiracetam—ABCC2—adrenal gland—breast cancer	0.000802	0.0225	CbGeAlD
Levetiracetam—ABCC2—endocrine gland—breast cancer	0.000696	0.0195	CbGeAlD
Levetiracetam—ABCB1—embryo—breast cancer	0.000488	0.0137	CbGeAlD
Levetiracetam—ABCC2—lymph node—breast cancer	0.000481	0.0135	CbGeAlD
Levetiracetam—ABCB1—epithelium—breast cancer	0.000398	0.0112	CbGeAlD
Levetiracetam—ABCB1—endometrium—breast cancer	0.000357	0.01	CbGeAlD
Levetiracetam—ABCB1—uterus—breast cancer	0.000329	0.00921	CbGeAlD
Levetiracetam—ABCB1—pituitary gland—breast cancer	0.000323	0.00905	CbGeAlD
Levetiracetam—ABCB1—adipose tissue—breast cancer	0.000322	0.00901	CbGeAlD
Levetiracetam—ABCB1—female reproductive system—breast cancer	0.000296	0.00828	CbGeAlD
Levetiracetam—ABCB1—adrenal gland—breast cancer	0.000288	0.00808	CbGeAlD
Levetiracetam—ABCB1—bone marrow—breast cancer	0.000279	0.00782	CbGeAlD
Levetiracetam—ABCB1—female gonad—breast cancer	0.000269	0.00754	CbGeAlD
Levetiracetam—ABCB1—endocrine gland—breast cancer	0.00025	0.00701	CbGeAlD
Levetiracetam—ABCB1—lymph node—breast cancer	0.000173	0.00485	CbGeAlD
Levetiracetam—SV2A—Disease—FGFR1—breast cancer	7.83e-05	0.00118	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—AGTR1—breast cancer	7.76e-05	0.00117	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SMAD4—breast cancer	7.74e-05	0.00117	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HIF1A—breast cancer	7.71e-05	0.00117	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC39A6—breast cancer	7.59e-05	0.00115	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CAV1—breast cancer	7.45e-05	0.00113	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—breast cancer	7.08e-05	0.00107	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS2—breast cancer	7.01e-05	0.00106	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MRE11A—breast cancer	6.99e-05	0.00106	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP7B—breast cancer	6.94e-05	0.00105	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOTCH1—breast cancer	6.94e-05	0.00105	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FST—breast cancer	6.81e-05	0.00103	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APC—breast cancer	6.79e-05	0.00103	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KIT—breast cancer	6.79e-05	0.00103	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGF—breast cancer	6.71e-05	0.00101	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TERT—breast cancer	6.62e-05	0.001	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCC1—breast cancer	6.46e-05	0.000976	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BRAF—breast cancer	6.38e-05	0.000965	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—breast cancer	6.33e-05	0.000957	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC28A1—breast cancer	6.22e-05	0.00094	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT2—breast cancer	6.21e-05	0.000939	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—LEP—breast cancer	6.18e-05	0.000934	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—HRAS—breast cancer	6.03e-05	0.000911	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CD—breast cancer	5.97e-05	0.000902	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—breast cancer	5.94e-05	0.000899	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SERPINE1—breast cancer	5.9e-05	0.000893	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—breast cancer	5.79e-05	0.000876	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NOS2—breast cancer	5.76e-05	0.000871	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A10—breast cancer	5.68e-05	0.000859	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC4A7—breast cancer	5.68e-05	0.000859	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS3—breast cancer	5.64e-05	0.000852	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TUBB3—breast cancer	5.49e-05	0.00083	CbGpPWpGaD
Levetiracetam—Erythema multiforme—Methotrexate—breast cancer	5.41e-05	0.000235	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—breast cancer	5.41e-05	0.000818	CbGpPWpGaD
Levetiracetam—Dizziness—Irinotecan—breast cancer	5.4e-05	0.000234	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—breast cancer	5.38e-05	0.000233	CcSEcCtD
Levetiracetam—Anorexia—Docetaxel—breast cancer	5.38e-05	0.000233	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—breast cancer	5.37e-05	0.000233	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—breast cancer	5.37e-05	0.000233	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—breast cancer	5.37e-05	0.000233	CcSEcCtD
Levetiracetam—Nervous system disorder—Capecitabine—breast cancer	5.36e-05	0.000232	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—breast cancer	5.36e-05	0.000232	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—breast cancer	5.35e-05	0.000232	CcSEcCtD
Levetiracetam—Diarrhoea—Fluorouracil—breast cancer	5.35e-05	0.000232	CcSEcCtD
Levetiracetam—Thrombocytopenia—Capecitabine—breast cancer	5.35e-05	0.000232	CcSEcCtD
Levetiracetam—SV2A—Disease—MDM2—breast cancer	5.35e-05	0.000808	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RAF1—breast cancer	5.33e-05	0.000806	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—FOS—breast cancer	5.32e-05	0.000804	CbGpPWpGaD
Levetiracetam—Pharyngitis—Epirubicin—breast cancer	5.32e-05	0.00023	CcSEcCtD
Levetiracetam—Skin disorder—Capecitabine—breast cancer	5.31e-05	0.00023	CcSEcCtD
Levetiracetam—SV2A—Disease—ERBB2—breast cancer	5.27e-05	0.000797	CbGpPWpGaD
Levetiracetam—Connective tissue disorder—Epirubicin—breast cancer	5.26e-05	0.000228	CcSEcCtD
Levetiracetam—Abdominal pain—Paclitaxel—breast cancer	5.26e-05	0.000228	CcSEcCtD
Levetiracetam—Body temperature increased—Paclitaxel—breast cancer	5.26e-05	0.000228	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—breast cancer	5.22e-05	0.000226	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—breast cancer	5.21e-05	0.000226	CcSEcCtD
Levetiracetam—Anorexia—Capecitabine—breast cancer	5.21e-05	0.000226	CcSEcCtD
Levetiracetam—SV2A—Disease—MTOR—breast cancer	5.2e-05	0.000787	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CB—breast cancer	5.2e-05	0.000787	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—breast cancer	5.2e-05	0.000786	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD4—breast cancer	5.19e-05	0.000785	CbGpPWpGaD
Levetiracetam—Vomiting—Mitoxantrone—breast cancer	5.19e-05	0.000225	CcSEcCtD
Levetiracetam—Vomiting—Irinotecan—breast cancer	5.19e-05	0.000225	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—breast cancer	5.18e-05	0.000224	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—breast cancer	5.17e-05	0.000224	CcSEcCtD
Levetiracetam—Dizziness—Fluorouracil—breast cancer	5.17e-05	0.000224	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—breast cancer	5.16e-05	0.000781	CbGpPWpGaD
Levetiracetam—Mediastinal disorder—Methotrexate—breast cancer	5.16e-05	0.000224	CcSEcCtD
Levetiracetam—SV2A—Disease—PTGS2—breast cancer	5.16e-05	0.000779	CbGpPWpGaD
Levetiracetam—Agranulocytosis—Doxorubicin—breast cancer	5.15e-05	0.000223	CcSEcCtD
Levetiracetam—Rash—Irinotecan—breast cancer	5.15e-05	0.000223	CcSEcCtD
Levetiracetam—Rash—Mitoxantrone—breast cancer	5.15e-05	0.000223	CcSEcCtD
Levetiracetam—Dermatitis—Irinotecan—breast cancer	5.14e-05	0.000223	CcSEcCtD
Levetiracetam—Dermatitis—Mitoxantrone—breast cancer	5.14e-05	0.000223	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Docetaxel—breast cancer	5.14e-05	0.000223	CcSEcCtD
Levetiracetam—Headache—Irinotecan—breast cancer	5.11e-05	0.000222	CcSEcCtD
Levetiracetam—Headache—Mitoxantrone—breast cancer	5.11e-05	0.000222	CcSEcCtD
Levetiracetam—Insomnia—Docetaxel—breast cancer	5.1e-05	0.000221	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—breast cancer	5.09e-05	0.00077	CbGpPWpGaD
Levetiracetam—Paraesthesia—Docetaxel—breast cancer	5.07e-05	0.00022	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—breast cancer	5.06e-05	0.000219	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—breast cancer	5.06e-05	0.000219	CcSEcCtD
Levetiracetam—Vomiting—Gemcitabine—breast cancer	5.06e-05	0.000219	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—breast cancer	5.04e-05	0.000762	CbGpPWpGaD
Levetiracetam—Somnolence—Docetaxel—breast cancer	5.02e-05	0.000217	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—breast cancer	5.01e-05	0.000217	CcSEcCtD
Levetiracetam—Rash—Gemcitabine—breast cancer	5.01e-05	0.000217	CcSEcCtD
Levetiracetam—Dermatitis—Gemcitabine—breast cancer	5.01e-05	0.000217	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—breast cancer	5.01e-05	0.000217	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—breast cancer	4.98e-05	0.000216	CcSEcCtD
Levetiracetam—Headache—Gemcitabine—breast cancer	4.98e-05	0.000216	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Capecitabine—breast cancer	4.98e-05	0.000216	CcSEcCtD
Levetiracetam—Vomiting—Fluorouracil—breast cancer	4.97e-05	0.000215	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—breast cancer	4.97e-05	0.000215	CcSEcCtD
Levetiracetam—Dyspepsia—Docetaxel—breast cancer	4.97e-05	0.000215	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—breast cancer	4.96e-05	0.000215	CcSEcCtD
Levetiracetam—Insomnia—Capecitabine—breast cancer	4.94e-05	0.000214	CcSEcCtD
Levetiracetam—Rash—Fluorouracil—breast cancer	4.93e-05	0.000214	CcSEcCtD
Levetiracetam—Dermatitis—Fluorouracil—breast cancer	4.92e-05	0.000213	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—breast cancer	4.92e-05	0.000213	CcSEcCtD
Levetiracetam—Paraesthesia—Capecitabine—breast cancer	4.91e-05	0.000213	CcSEcCtD
Levetiracetam—Decreased appetite—Docetaxel—breast cancer	4.9e-05	0.000213	CcSEcCtD
Levetiracetam—Hypersensitivity—Paclitaxel—breast cancer	4.9e-05	0.000213	CcSEcCtD
Levetiracetam—Headache—Fluorouracil—breast cancer	4.9e-05	0.000212	CcSEcCtD
Levetiracetam—SV2A—Disease—CDKN1B—breast cancer	4.88e-05	0.000738	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Docetaxel—breast cancer	4.87e-05	0.000211	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—breast cancer	4.87e-05	0.000211	CcSEcCtD
Levetiracetam—Fatigue—Docetaxel—breast cancer	4.86e-05	0.000211	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—breast cancer	4.85e-05	0.000733	CbGpPWpGaD
Levetiracetam—Nausea—Mitoxantrone—breast cancer	4.85e-05	0.00021	CcSEcCtD
Levetiracetam—Nausea—Irinotecan—breast cancer	4.85e-05	0.00021	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—breast cancer	4.84e-05	0.00021	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—breast cancer	4.83e-05	0.000209	CcSEcCtD
Levetiracetam—Constipation—Docetaxel—breast cancer	4.83e-05	0.000209	CcSEcCtD
Levetiracetam—Pain—Docetaxel—breast cancer	4.83e-05	0.000209	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—breast cancer	4.82e-05	0.000209	CcSEcCtD
Levetiracetam—Dyspepsia—Capecitabine—breast cancer	4.81e-05	0.000208	CcSEcCtD
Levetiracetam—Asthenia—Paclitaxel—breast cancer	4.78e-05	0.000207	CcSEcCtD
Levetiracetam—Decreased appetite—Capecitabine—breast cancer	4.75e-05	0.000206	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—breast cancer	4.73e-05	0.000205	CcSEcCtD
Levetiracetam—Nausea—Gemcitabine—breast cancer	4.72e-05	0.000205	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—breast cancer	4.72e-05	0.000714	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Capecitabine—breast cancer	4.72e-05	0.000204	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC39A7—breast cancer	4.71e-05	0.000712	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—COX11—breast cancer	4.71e-05	0.000712	CbGpPWpGaD
Levetiracetam—Fatigue—Capecitabine—breast cancer	4.71e-05	0.000204	CcSEcCtD
Levetiracetam—Pruritus—Paclitaxel—breast cancer	4.71e-05	0.000204	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	4.7e-05	0.00071	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	4.7e-05	0.00071	CbGpPWpGaD
Levetiracetam—Vision blurred—Methotrexate—breast cancer	4.7e-05	0.000204	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—breast cancer	4.69e-05	0.000203	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—breast cancer	4.69e-05	0.000203	CcSEcCtD
Levetiracetam—Constipation—Capecitabine—breast cancer	4.67e-05	0.000202	CcSEcCtD
Levetiracetam—Pain—Capecitabine—breast cancer	4.67e-05	0.000202	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—breast cancer	4.66e-05	0.000202	CcSEcCtD
Levetiracetam—Feeling abnormal—Docetaxel—breast cancer	4.65e-05	0.000201	CcSEcCtD
Levetiracetam—Nausea—Fluorouracil—breast cancer	4.64e-05	0.000201	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—breast cancer	4.63e-05	0.000201	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Docetaxel—breast cancer	4.61e-05	0.0002	CcSEcCtD
Levetiracetam—SV2A—Disease—CTNNB1—breast cancer	4.61e-05	0.000697	CbGpPWpGaD
Levetiracetam—Tension—Epirubicin—breast cancer	4.58e-05	0.000198	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.57e-05	0.00069	CbGpPWpGaD
Levetiracetam—Diarrhoea—Paclitaxel—breast cancer	4.55e-05	0.000197	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—breast cancer	4.53e-05	0.000196	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—breast cancer	4.51e-05	0.000195	CcSEcCtD
Levetiracetam—SV2A—Disease—CDKN1A—breast cancer	4.51e-05	0.000681	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Capecitabine—breast cancer	4.5e-05	0.000195	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CASP8—breast cancer	4.5e-05	0.00068	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—breast cancer	4.5e-05	0.00068	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	4.49e-05	0.000678	CbGpPWpGaD
Levetiracetam—Immune system disorder—Doxorubicin—breast cancer	4.48e-05	0.000194	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—breast cancer	4.48e-05	0.000194	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG2—breast cancer	4.47e-05	0.000676	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Capecitabine—breast cancer	4.47e-05	0.000194	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—breast cancer	4.47e-05	0.000194	CcSEcCtD
Levetiracetam—Abdominal pain—Docetaxel—breast cancer	4.46e-05	0.000193	CcSEcCtD
Levetiracetam—Body temperature increased—Docetaxel—breast cancer	4.46e-05	0.000193	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—breast cancer	4.46e-05	0.000193	CcSEcCtD
Levetiracetam—Dizziness—Paclitaxel—breast cancer	4.4e-05	0.000191	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—breast cancer	4.39e-05	0.00019	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—breast cancer	4.38e-05	0.00019	CcSEcCtD
Levetiracetam—Cough—Methotrexate—breast cancer	4.35e-05	0.000188	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—breast cancer	4.34e-05	0.000188	CcSEcCtD
Levetiracetam—Abdominal pain—Capecitabine—breast cancer	4.32e-05	0.000187	CcSEcCtD
Levetiracetam—Body temperature increased—Capecitabine—breast cancer	4.32e-05	0.000187	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—breast cancer	4.32e-05	0.000187	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—breast cancer	4.31e-05	0.000187	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC22A18—breast cancer	4.31e-05	0.000651	CbGpPWpGaD
Levetiracetam—Agitation—Epirubicin—breast cancer	4.29e-05	0.000186	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—breast cancer	4.24e-05	0.000184	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—breast cancer	4.24e-05	0.000184	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—breast cancer	4.24e-05	0.000184	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—breast cancer	4.23e-05	0.000183	CcSEcCtD
Levetiracetam—Vomiting—Paclitaxel—breast cancer	4.23e-05	0.000183	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.21e-05	0.000183	CcSEcCtD
Levetiracetam—Rash—Paclitaxel—breast cancer	4.2e-05	0.000182	CcSEcCtD
Levetiracetam—Dermatitis—Paclitaxel—breast cancer	4.19e-05	0.000182	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—breast cancer	4.19e-05	0.000182	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—breast cancer	4.19e-05	0.000182	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—breast cancer	4.17e-05	0.000181	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—breast cancer	4.17e-05	0.000181	CcSEcCtD
Levetiracetam—Headache—Paclitaxel—breast cancer	4.17e-05	0.000181	CcSEcCtD
Levetiracetam—SV2A—Disease—SRC—breast cancer	4.17e-05	0.00063	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	4.16e-05	0.000629	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	4.16e-05	0.000629	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Docetaxel—breast cancer	4.16e-05	0.00018	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	4.15e-05	0.000627	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A5—breast cancer	4.15e-05	0.000627	CbGpPWpGaD
Levetiracetam—Confusional state—Methotrexate—breast cancer	4.1e-05	0.000178	CcSEcCtD
Levetiracetam—Cough—Epirubicin—breast cancer	4.07e-05	0.000176	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—breast cancer	4.07e-05	0.000176	CcSEcCtD
Levetiracetam—Asthenia—Docetaxel—breast cancer	4.05e-05	0.000175	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—breast cancer	4.04e-05	0.000175	CcSEcCtD
Levetiracetam—Infection—Methotrexate—breast cancer	4.04e-05	0.000175	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	4.03e-05	0.000609	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Capecitabine—breast cancer	4.02e-05	0.000174	CcSEcCtD
Levetiracetam—SV2A—Disease—STAT3—breast cancer	4.02e-05	0.000608	CbGpPWpGaD
Levetiracetam—Pruritus—Docetaxel—breast cancer	3.99e-05	0.000173	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TFRC—breast cancer	3.99e-05	0.000603	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Methotrexate—breast cancer	3.99e-05	0.000173	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—breast cancer	3.98e-05	0.000173	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—breast cancer	3.97e-05	0.000172	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—breast cancer	3.97e-05	0.000172	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—breast cancer	3.97e-05	0.000172	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—breast cancer	3.97e-05	0.000172	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—breast cancer	3.96e-05	0.000171	CcSEcCtD
Levetiracetam—Nausea—Paclitaxel—breast cancer	3.95e-05	0.000171	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—breast cancer	3.95e-05	0.000171	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.94e-05	0.000171	CcSEcCtD
Levetiracetam—Asthenia—Capecitabine—breast cancer	3.92e-05	0.00017	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—breast cancer	3.89e-05	0.000589	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	3.89e-05	0.000588	CbGpPWpGaD
Levetiracetam—Vertigo—Doxorubicin—breast cancer	3.88e-05	0.000168	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—breast cancer	3.88e-05	0.000168	CcSEcCtD
Levetiracetam—Pruritus—Capecitabine—breast cancer	3.87e-05	0.000167	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—breast cancer	3.86e-05	0.000167	CcSEcCtD
Levetiracetam—Diarrhoea—Docetaxel—breast cancer	3.86e-05	0.000167	CcSEcCtD
Levetiracetam—SV2A—Disease—MAPK3—breast cancer	3.84e-05	0.000581	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NCOA2—breast cancer	3.84e-05	0.00058	CbGpPWpGaD
Levetiracetam—Confusional state—Epirubicin—breast cancer	3.84e-05	0.000166	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IFNG—breast cancer	3.83e-05	0.000578	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—JUN—breast cancer	3.82e-05	0.000577	CbGpPWpGaD
Levetiracetam—Infection—Epirubicin—breast cancer	3.78e-05	0.000164	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	3.78e-05	0.000571	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	3.78e-05	0.000571	CbGpPWpGaD
Levetiracetam—Cough—Doxorubicin—breast cancer	3.77e-05	0.000163	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—breast cancer	3.74e-05	0.000162	CcSEcCtD
Levetiracetam—Diarrhoea—Capecitabine—breast cancer	3.74e-05	0.000162	CcSEcCtD
Levetiracetam—SV2A—Disease—MYC—breast cancer	3.74e-05	0.000565	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Epirubicin—breast cancer	3.73e-05	0.000162	CcSEcCtD
Levetiracetam—Dizziness—Docetaxel—breast cancer	3.73e-05	0.000162	CcSEcCtD
Levetiracetam—SV2A—Disease—TGFB1—breast cancer	3.73e-05	0.000563	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Epirubicin—breast cancer	3.73e-05	0.000161	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—breast cancer	3.71e-05	0.000161	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—breast cancer	3.7e-05	0.00016	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—breast cancer	3.68e-05	0.000159	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—breast cancer	3.67e-05	0.000159	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—breast cancer	3.67e-05	0.000159	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—breast cancer	3.67e-05	0.000159	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AR—breast cancer	3.67e-05	0.000555	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.66e-05	0.000554	CbGpPWpGaD
Levetiracetam—Anxiety—Doxorubicin—breast cancer	3.66e-05	0.000159	CcSEcCtD
Levetiracetam—SV2A—Disease—EGFR—breast cancer	3.65e-05	0.000552	CbGpPWpGaD
Levetiracetam—Paraesthesia—Methotrexate—breast cancer	3.65e-05	0.000158	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.65e-05	0.000158	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—breast cancer	3.63e-05	0.000157	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—breast cancer	3.62e-05	0.000157	CcSEcCtD
Levetiracetam—Dizziness—Capecitabine—breast cancer	3.61e-05	0.000157	CcSEcCtD
Levetiracetam—Vomiting—Docetaxel—breast cancer	3.59e-05	0.000155	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—breast cancer	3.58e-05	0.000155	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC39A6—breast cancer	3.57e-05	0.00054	CbGpPWpGaD
Levetiracetam—Rash—Docetaxel—breast cancer	3.56e-05	0.000154	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CXCL8—breast cancer	3.56e-05	0.000538	CbGpPWpGaD
Levetiracetam—Dermatitis—Docetaxel—breast cancer	3.55e-05	0.000154	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—breast cancer	3.55e-05	0.000154	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	3.54e-05	0.000536	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.54e-05	0.000535	CbGpPWpGaD
Levetiracetam—Decreased appetite—Methotrexate—breast cancer	3.54e-05	0.000153	CcSEcCtD
Levetiracetam—Headache—Docetaxel—breast cancer	3.53e-05	0.000153	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—breast cancer	3.51e-05	0.000152	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—breast cancer	3.51e-05	0.000152	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—breast cancer	3.5e-05	0.000152	CcSEcCtD
Levetiracetam—Pain—Methotrexate—breast cancer	3.48e-05	0.000151	CcSEcCtD
Levetiracetam—Vomiting—Capecitabine—breast cancer	3.47e-05	0.000151	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—breast cancer	3.47e-05	0.00015	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—breast cancer	3.45e-05	0.00015	CcSEcCtD
Levetiracetam—SV2A—Disease—KRAS—breast cancer	3.45e-05	0.000522	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—breast cancer	3.45e-05	0.000522	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Doxorubicin—breast cancer	3.45e-05	0.000149	CcSEcCtD
Levetiracetam—Rash—Capecitabine—breast cancer	3.44e-05	0.000149	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—breast cancer	3.44e-05	0.000149	CcSEcCtD
Levetiracetam—Dermatitis—Capecitabine—breast cancer	3.44e-05	0.000149	CcSEcCtD
Levetiracetam—Headache—Capecitabine—breast cancer	3.42e-05	0.000148	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—breast cancer	3.42e-05	0.000148	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—breast cancer	3.42e-05	0.000148	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	3.41e-05	0.000516	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	3.41e-05	0.000516	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	3.41e-05	0.000516	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—breast cancer	3.41e-05	0.000516	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—breast cancer	3.4e-05	0.000515	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—breast cancer	3.4e-05	0.000514	CbGpPWpGaD
Levetiracetam—Somnolence—Epirubicin—breast cancer	3.38e-05	0.000147	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—breast cancer	3.36e-05	0.000145	CcSEcCtD
Levetiracetam—Nausea—Docetaxel—breast cancer	3.35e-05	0.000145	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—breast cancer	3.35e-05	0.000145	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—breast cancer	3.35e-05	0.000145	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	3.35e-05	0.000506	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	3.34e-05	0.000504	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Methotrexate—breast cancer	3.33e-05	0.000144	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—breast cancer	3.31e-05	0.000143	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	3.31e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	3.31e-05	0.0005	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Epirubicin—breast cancer	3.29e-05	0.000142	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—breast cancer	3.28e-05	0.000142	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	3.26e-05	0.000494	CbGpPWpGaD
Levetiracetam—Pain—Epirubicin—breast cancer	3.25e-05	0.000141	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—breast cancer	3.25e-05	0.000141	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	3.25e-05	0.000491	CbGpPWpGaD
Levetiracetam—Nausea—Capecitabine—breast cancer	3.24e-05	0.000141	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NCOA1—breast cancer	3.24e-05	0.000489	CbGpPWpGaD
Levetiracetam—Abdominal pain—Methotrexate—breast cancer	3.21e-05	0.000139	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—breast cancer	3.21e-05	0.000139	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	3.21e-05	0.000485	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.21e-05	0.000139	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—breast cancer	3.18e-05	0.000138	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	3.17e-05	0.00048	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CA—breast cancer	3.17e-05	0.000479	CbGpPWpGaD
Levetiracetam—Paraesthesia—Doxorubicin—breast cancer	3.16e-05	0.000137	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PLG—breast cancer	3.15e-05	0.000477	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Epirubicin—breast cancer	3.14e-05	0.000136	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—breast cancer	3.13e-05	0.000136	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	3.13e-05	0.000473	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Epirubicin—breast cancer	3.11e-05	0.000135	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	3.11e-05	0.00047	CbGpPWpGaD
Levetiracetam—Dyspepsia—Doxorubicin—breast cancer	3.1e-05	0.000134	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—breast cancer	3.06e-05	0.000133	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—breast cancer	3.04e-05	0.000132	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—breast cancer	3.04e-05	0.000132	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	3.04e-05	0.000459	CbGpPWpGaD
Levetiracetam—Pain—Doxorubicin—breast cancer	3.01e-05	0.00013	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—breast cancer	3.01e-05	0.00013	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—breast cancer	3.01e-05	0.00013	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—breast cancer	3.01e-05	0.00013	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—breast cancer	3e-05	0.00013	CcSEcCtD
Levetiracetam—SV2A—Disease—HRAS—breast cancer	2.93e-05	0.000444	CbGpPWpGaD
Levetiracetam—Asthenia—Methotrexate—breast cancer	2.92e-05	0.000126	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—HMOX1—breast cancer	2.91e-05	0.00044	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Doxorubicin—breast cancer	2.9e-05	0.000126	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—breast cancer	2.89e-05	0.000437	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Doxorubicin—breast cancer	2.88e-05	0.000125	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—breast cancer	2.88e-05	0.000125	CcSEcCtD
Levetiracetam—SV2A—Disease—IL6—breast cancer	2.81e-05	0.000425	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Epirubicin—breast cancer	2.8e-05	0.000122	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—breast cancer	2.79e-05	0.000422	CbGpPWpGaD
Levetiracetam—Body temperature increased—Doxorubicin—breast cancer	2.78e-05	0.000121	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—breast cancer	2.78e-05	0.000121	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—breast cancer	2.78e-05	0.000121	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	2.75e-05	0.000415	CbGpPWpGaD
Levetiracetam—Asthenia—Epirubicin—breast cancer	2.73e-05	0.000118	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—breast cancer	2.69e-05	0.000117	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—breast cancer	2.69e-05	0.000117	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	2.68e-05	0.000405	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SYNJ2—breast cancer	2.66e-05	0.000403	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—breast cancer	2.65e-05	0.000401	CbGpPWpGaD
Levetiracetam—Diarrhoea—Epirubicin—breast cancer	2.6e-05	0.000113	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—breast cancer	2.59e-05	0.000112	CcSEcCtD
Levetiracetam—SV2A—Disease—AKT1—breast cancer	2.59e-05	0.000392	CbGpPWpGaD
Levetiracetam—Vomiting—Methotrexate—breast cancer	2.59e-05	0.000112	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	2.58e-05	0.00039	CbGpPWpGaD
Levetiracetam—Rash—Methotrexate—breast cancer	2.56e-05	0.000111	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—breast cancer	2.56e-05	0.000111	CcSEcCtD
Levetiracetam—Headache—Methotrexate—breast cancer	2.55e-05	0.00011	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	2.54e-05	0.000384	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	2.53e-05	0.000383	CbGpPWpGaD
Levetiracetam—Asthenia—Doxorubicin—breast cancer	2.53e-05	0.000109	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	2.52e-05	0.000381	CbGpPWpGaD
Levetiracetam—Dizziness—Epirubicin—breast cancer	2.52e-05	0.000109	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—breast cancer	2.49e-05	0.000108	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—TNF—breast cancer	2.48e-05	0.000374	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NDUFS3—breast cancer	2.48e-05	0.000374	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	2.46e-05	0.000372	CbGpPWpGaD
Levetiracetam—Vomiting—Epirubicin—breast cancer	2.42e-05	0.000105	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—breast cancer	2.42e-05	0.000105	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—breast cancer	2.41e-05	0.000104	CcSEcCtD
Levetiracetam—Rash—Epirubicin—breast cancer	2.4e-05	0.000104	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—breast cancer	2.4e-05	0.000104	CcSEcCtD
Levetiracetam—Headache—Epirubicin—breast cancer	2.38e-05	0.000103	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	2.38e-05	0.00036	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	2.36e-05	0.000356	CbGpPWpGaD
Levetiracetam—Dizziness—Doxorubicin—breast cancer	2.33e-05	0.000101	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—CHST9—breast cancer	2.33e-05	0.000352	CbGpPWpGaD
Levetiracetam—Nausea—Epirubicin—breast cancer	2.26e-05	9.8e-05	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—breast cancer	2.24e-05	9.7e-05	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—breast cancer	2.22e-05	9.62e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	2.22e-05	0.000336	CbGpPWpGaD
Levetiracetam—Dermatitis—Doxorubicin—breast cancer	2.22e-05	9.61e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—COX11—breast cancer	2.21e-05	0.000334	CbGpPWpGaD
Levetiracetam—Headache—Doxorubicin—breast cancer	2.21e-05	9.56e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	2.18e-05	0.00033	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.15e-05	0.000325	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	2.13e-05	0.000322	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	2.1e-05	0.000318	CbGpPWpGaD
Levetiracetam—Nausea—Doxorubicin—breast cancer	2.09e-05	9.06e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—CDA—breast cancer	2.02e-05	0.000305	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SHMT1—breast cancer	2.02e-05	0.000305	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLCO1B1—breast cancer	1.94e-05	0.000294	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A5—breast cancer	1.94e-05	0.000294	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.91e-05	0.000288	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.88e-05	0.000284	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APRT—breast cancer	1.88e-05	0.000284	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.88e-05	0.000283	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.87e-05	0.000283	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.85e-05	0.00028	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.81e-05	0.000274	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.81e-05	0.000273	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ESRRA—breast cancer	1.76e-05	0.000267	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ANGPTL4—breast cancer	1.76e-05	0.000267	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—breast cancer	1.75e-05	0.000264	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.72e-05	0.00026	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.71e-05	0.000259	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.68e-05	0.000254	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPI—breast cancer	1.67e-05	0.000253	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HADHB—breast cancer	1.67e-05	0.000253	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.66e-05	0.000251	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.64e-05	0.000247	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.63e-05	0.000247	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.62e-05	0.000245	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDH7A1—breast cancer	1.59e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDH1A1—breast cancer	1.59e-05	0.000241	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.58e-05	0.000239	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—RAF1—breast cancer	1.58e-05	0.000239	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.58e-05	0.000239	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.54e-05	0.000233	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FHL2—breast cancer	1.53e-05	0.000231	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NME1—breast cancer	1.53e-05	0.000231	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UMPS—breast cancer	1.53e-05	0.000231	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADSL—breast cancer	1.53e-05	0.000231	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PHGDH—breast cancer	1.53e-05	0.000231	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.52e-05	0.00023	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HPSE—breast cancer	1.5e-05	0.000227	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LDHB—breast cancer	1.5e-05	0.000227	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BRIP1—breast cancer	1.5e-05	0.000227	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.48e-05	0.000224	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.46e-05	0.000221	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.43e-05	0.000216	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCC1—breast cancer	1.42e-05	0.000215	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA3—breast cancer	1.42e-05	0.000215	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMMR—breast cancer	1.42e-05	0.000215	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARGC1B—breast cancer	1.38e-05	0.000208	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.37e-05	0.000207	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.35e-05	0.000204	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.31e-05	0.000198	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.31e-05	0.000198	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA4—breast cancer	1.3e-05	0.000197	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CA9—breast cancer	1.3e-05	0.000197	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.28e-05	0.000194	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA2—breast cancer	1.27e-05	0.000192	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX2—breast cancer	1.27e-05	0.000192	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX4—breast cancer	1.25e-05	0.000189	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SULT1A1—breast cancer	1.25e-05	0.000189	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—IDH1—breast cancer	1.22e-05	0.000185	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA1—breast cancer	1.22e-05	0.000185	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.22e-05	0.000185	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.21e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAT2—breast cancer	1.21e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.11e-05	0.000168	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.08e-05	0.000163	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MED12—breast cancer	1.06e-05	0.00016	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—DPYD—breast cancer	1.06e-05	0.00016	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDOA—breast cancer	1.04e-05	0.000158	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA3—breast cancer	1.01e-05	0.000153	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A2—breast cancer	1.01e-05	0.000152	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CPT1A—breast cancer	9.85e-06	0.000149	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG2—breast cancer	9.85e-06	0.000149	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTR—breast cancer	9.85e-06	0.000149	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HPGDS—breast cancer	9.66e-06	0.000146	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HBA1—breast cancer	9.6e-06	0.000145	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTT1—breast cancer	9.37e-06	0.000142	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACHE—breast cancer	9.37e-06	0.000142	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	9.1e-06	0.000138	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP17A1—breast cancer	8.87e-06	0.000134	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ENO1—breast cancer	8.78e-06	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS1—breast cancer	8.78e-06	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2D6—breast cancer	8.61e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA2—breast cancer	8.45e-06	0.000128	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	8.21e-06	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FASN—breast cancer	8.2e-06	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BCHE—breast cancer	8.17e-06	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A5—breast cancer	8.07e-06	0.000122	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC2A1—breast cancer	7.79e-06	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NQO1—breast cancer	7.79e-06	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP3A4—breast cancer	7.6e-06	0.000115	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1B1—breast cancer	7.47e-06	0.000113	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	7.43e-06	0.000112	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSP90AA1—breast cancer	7.32e-06	0.000111	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA1—breast cancer	7.12e-06	0.000108	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—STK11—breast cancer	7.02e-06	0.000106	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP19A1—breast cancer	7.02e-06	0.000106	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—COMT—breast cancer	6.53e-06	9.87e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTP1—breast cancer	6.5e-06	9.82e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMOX1—breast cancer	6.41e-06	9.69e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ITPR1—breast cancer	6.39e-06	9.66e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TYMS—breast cancer	6.04e-06	9.13e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOR1—breast cancer	5.97e-06	9.03e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—breast cancer	5.97e-06	9.03e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLA2G4A—breast cancer	5.97e-06	9.03e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX1—breast cancer	5.72e-06	8.64e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1A1—breast cancer	5.66e-06	8.56e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ERCC2—breast cancer	5.61e-06	8.49e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—breast cancer	5.28e-06	7.98e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAV1—breast cancer	4.87e-06	7.36e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—breast cancer	4.43e-06	6.7e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CD—breast cancer	3.9e-06	5.89e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—breast cancer	3.85e-06	5.82e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NOS3—breast cancer	3.68e-06	5.56e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CB—breast cancer	3.4e-06	5.14e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—breast cancer	3.37e-06	5.09e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—breast cancer	2.94e-06	4.44e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—breast cancer	2.07e-06	3.13e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—breast cancer	1.69e-06	2.56e-05	CbGpPWpGaD
